
OPCH Stock Forecast & Price Target
OPCH Analyst Ratings
Bulls say
Option Care Health is facing some challenges with investor confidence due to mixed performance in Q1 and lowered guidance for FY/26. However, the company maintains a strong position in the specialty pharmacy market with a 30% market share and 50 limited distribution drugs, giving it economies of scale and operating leverage. With a strong balance sheet and potential for future capital deployment, Option Care Health is well positioned for future growth.
Bears say
Option Care Health is facing significant challenges in meeting its 2026 financial targets, with a mix of unexpected headwinds in Stelara-related therapies and a steep ramp in adjusted EBITDA growth needed in the second half of the year. These concerns, along with potential company-specific risks such as slower growth and increased competition, drive our negative outlook on the stock.
This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.
OPCH Analyst Forecast & Price Prediction
Start investing in OPCH
Order type
Buy in
Order amount
Est. shares
0 shares